IMPROVING LIVES AROUND THE WORLD BY ACCELERATED IVD DEVELOPMENT
The Medtechtomarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.
PROJECT TIMELINE
2015
2023
INFECTIOUS DISEASE DIAGNOSTIC PCR LAB TEST
IVD Product Development, Currently Ongoing
IMMUNOCHEMISTRY DIAGNOSTIC LAB TEST
Early Proof of Concept and Productization, Currently in Development
HIP DYSPLASIA MEDICAL DEVICE
Prototype Development and Pilot Clinical Study
EMERGENCY MEDICINE NEAR PATIENT TEST PLATFORM
Patent Filed and in Development
POC MOLECULAR DIAGNOSTIC TEST SYSTEM
Patent Filed and in Development
POC IMMUNOCHEMISTRY DIAGNOSTIC PLATFORM
IP Filed and in Development, SBRI Phase 1 Award, SBRI Phase 2 Award
LATERAL FLOW COMPANION DIAGNOSTIC
Prototype Development
POC HAEMOSTASIS DIAGNOSTIC SYSTEM
Filed 3 New Patents and Developed Launch of CE Mark, Key Opinion Leader Publications Identified the Product as a Major Growth Driver in Coagulation Market (2019)
POC VETERINARY HAEMOSTASIS DIAGNOSTIC TEST
Full US Launch 2018, European Launch 2019, 5 Academic Publications within 6 Months, Adoption by 10 Top Academic Institutions
2000
2015
UROLOGY MEDICAL DEVICE
Investor Turnaround Project (2013-2015), Full Product Redesign, Manufacture and Launch in 18 Months
PRIMARY CARE RAPID ECG SYSTEM
Novel Prototype Developed and Patented 1000 Patient Clinical Trial
in2it
Fully Automated POC Hba1c Measurement Diabetes Disease Management and Screening. Over 20,000 Systems and 9 million Tests Sold in Over 50 Countries Worldwide
OSTEOSAL
Low Cost, Rapid and POC Urine Test for Osteoporosis and Bone Density Markers. Product Improvement, Manufacturing and Scale-up. Companion and Screening Diagnostic Distributed Through Takeda
HELISAL
Low Cost, Rapid and POC Serum Test for Helicobacter Pylori for Stomach Cancer and Ulcer Prevention. Product Manufacturing and Scale-up. Distribution through Becton Dickenson
GDX
Portable POC Hba1c Measurement Diabetes Disease Management and Screening. Product Design Turnaround, Launch and Fully Automated Scale-Up. >15,000 Systems and 7 million Tests Sold Worldwide. Global Distribution Agreements with Cholestech, Alere and Abbott
MICROMAT II
Portable POC Hba1c Measurement Diabetes Disease Management and Screening. Product Design Turnaround, Launch and Fully Automated Scale-Up. >15,000 Systems and 7 million Tests Sold Worldwide. Global Distribution Agreements with Bio-Rad
CASE STUDIES
The Medtechtomarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.
Point of Care Haemostasis
Working with a client based in the USA, we developed, manufactured and launched the world’s first…
Home-use Urology Monitor and Device
Medtechtomarket developed a urine collection and monitoring system for adults using indwelling catheters. Our system offered…
Rapid ECG
Medtechtomarket developed a wireless ECG device for use by professionals in primary, acute and hyper-acute care…
Rapid Near-Patient Sepsis Diagnosis
There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each…
OUR TECHNOLOGIES
Our highly qualified team combine their expertise across a range of technologies and disciplines along with their seamlessly integrated approach to develop medical diagnostics products at our accredited facilities.
Mechanical and Solid State Systems
From ECG technologies, viscosity measurements, microscopic vision systems and mechanical techniques, Medtechtomarket has developed a number of products that deliver diagnosis with a direct measurement of the patient or on the sample itself.
Photometric and Fluorescence-Based Assays
At Medtechtomarket, we have wide-ranging experience in developing technical optical test cartridge formats and instrumentation to deliver highly sensitive colormetric, turbidity or fluorescence assay detection systems for measuring single biomarkers, enzyme assays and panels.
Immunochemistry
From state-of-the-art microfluidic immunofluorescence to traditional lateral flow technologies, we employ a range of immunological techniques to determine markers for clinical chemistry and haematology point of care diagnostic applications.
Microfluidics
Utilising passive and active continuous-flow microfluidic approaches to channel blood and reagent samples into micro-cuvettes, flow channels, reaction chambers, electrochemistry and MEMS sensors we are able to measure a wide range of biochemical markers in a number of clinical applications.
REGISTER FOR INSIGHTS
The MedtechtoMarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.